Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;33(31):e2100150.
doi: 10.1002/adma.202100150. Epub 2021 Jun 19.

Engineering Single-Atomic Iron-Catalyst-Integrated 3D-Printed Bioscaffolds for Osteosarcoma Destruction with Antibacterial and Bone Defect Regeneration Bioactivity

Affiliations

Engineering Single-Atomic Iron-Catalyst-Integrated 3D-Printed Bioscaffolds for Osteosarcoma Destruction with Antibacterial and Bone Defect Regeneration Bioactivity

Liying Wang et al. Adv Mater. 2021 Aug.

Abstract

Effective antitumor therapeutics with distinctive bactericidal and osteogenic properties are in high demand for comprehensive osteosarcoma treatment. Here, a "scaffold engineering" strategy that integrates highly active single-atomic iron catalysts (FeSAC) into a 3D printed bioactive glass (BG) scaffold is reported. Based on the atomically dispersed iron species within the catalysts, the engineered FeSAC displays prominent Fenton catalytic activity to generate toxic hydroxyl radicals (•OH) in response to the microenvironment specific to osteosarcoma. In addition, the constructed FeSAC-BG scaffold can serve as a sophisticated biomaterial platform for efficient osteosarcoma ablation, with concomitant bacterial sterilization via localized hyperthermia-reinforced nanocatalytic therapeutics. The destruction of the osteosarcoma, as well as the bacterial foci, can be achieved, further preventing susceptible chronic osteomyelitis during osteogenesis. In particular, the engineered FeSAC-BG scaffold is identified with advances in accelerated osteoconduction and osteoinduction, ultimately contributing to the sophisticated therapeutics and management of osteosarcoma. This work broadens the biomedical potential of single-atom catalysts and offers a comprehensive clinically feasible strategy for overall osteosarcoma therapeutics, bacterial inhibition, and tissue regeneration.

Keywords: bioscaffolds; nanocatalytic therapy; osteogenesis; osteosarcoma; single-atom catalysts.

PubMed Disclaimer

References

    1. M. Kansara, M. W. Teng, M. J. Smyth, D. M. Thomas, Nat. Rev. Cancer 2014, 14, 722.
    1. Y. Chen, M. A. Di Grappa, S. D. Molyneux, T. D. McKee, P. Waterhouse, J. M. Penninger, R. Khokha, Sci. Transl. Med. 2015, 7, 317ra197.
    1. R. J. Grimer, Lancet Oncol. 2005, 6, 85.
    1. P. A. Meyers, J. H. Healey, A. J. Chou, L. H. Wexler, P. R. Merola, C. D. Morris, M. P. Laquaglia, M. G. Kellick, S. J. Abramson, R. Gorlick, Cancer 2011, 117, 1736.
    1. B. Chen, H. Xiang, S. Pan, L. Yu, T. Xu, Y. Chen, Adv. Funct. Mater. 2020, 30, 2002621.

MeSH terms

LinkOut - more resources